Idexx Laboratories Inc (IDXX) — Analysis Summary
Idexx Laboratories Inc (IDXX) has a market cap of $44.45B with year-over-year revenue growth of +10.4%. Net margin stands at 24.6%. The stock trades at a P/E ratio of 40.6.
Key Takeaways
- Revenue changed +10.4% year-over-year
- Net margin of 24.6%
- P/E ratio of 40.6
Compared to other companies in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector, IDXX posted revenue growth of +10.4% and trades at a P/E of 40.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.